AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts ANTX Hot Sheet
Join SI Premium – FREE
AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
- Curaleaf pushes back on Aurora's rejection of takeover bid
- Fed watchdog calls for stronger controls on information sharing
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
